Ombitasvir

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV)...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 20, 2016

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

02

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chroni...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 20, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

03

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-NaÃ¯ve Hepatitis C Virus Ge...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 21, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

04

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-NaÃ¯ve and Treatment-Experienced, Non...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 07, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

05

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 21, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

06

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase II

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On ...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 10, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase II

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

07

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic H...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 01, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

08

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase II/ Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 01, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase II/ Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

09

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatmen...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 19, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

10

AbbVie Inc

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Study Phase : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infec...

Details : Ombitasvir is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hepatitis C, Chronic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 13, 2015

Lead Product(s) : Ombitasvir

Therapeutic Area : Infections and Infectious Diseases

Highest Development Status : Phase III

Sponsor : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable